세계의 의료용 항균 코팅 시장 보고서(2025년)
Medical Antibacterial Coating Global Market Report 2025
상품코드 : 1769650
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의료용 항균 코팅 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 예상 성장 기간 동안의 성장은 외래 수술 센터의 확장, 만성 질환의 부담 증가, 최소 침습적 의료 기기 수요 증가, 환자 안전에 대한 관심 고조, 가정 의료 서비스 개발, 일회용 의료 제품 사용 증가, 엄격한 감염 관리 정책 시행, 의료 인프라 투자 확대, 선진 지역에서의 고령화 인구 증가, 내구성이 뛰어난 코팅 솔루션의 필요성 등과 연관될 수 있습니다. 이 기간 동안 예상되는 주요 동향으로는 나노 기술 기반 코팅의 출현, 바이오 기반 항균제 사용, 다기능 코팅 개발, 스마트 방출 코팅 시스템, 은 나노 입자의 통합, 폴리머 살생물제 코팅, 플라즈마 코팅 기술의 발전, 항균 펩타이드의 통합, 복합 항균 전략, 자체 세정 항균 표면 등이 있습니다.

병원 감염(HAI)의 증가로 인해 향후 의료용 항균 코팅 시장의 성장이 촉진될 것으로 예상됩니다. 병원 감염은 환자가 의료 시설에서 치료를 받는 동안에 감염되는 감염으로, 입원 당시에는 없었던 감염입니다. 병원 감염의 증가는 위험에 처한 환자들 사이에서 병원균의 전염을 촉진하는 과밀한 병원 환경과 같은 요인에 크게 기인합니다. 의료용 항균 코팅은 의료 기기 및 표면에서 유해 미생물의 성장과 확산을 방지함으로써 감염을 완화하고 위생 기준을 향상시키며 환자 안전을 보장합니다. 예를 들어, 2025년 4월 호주 보건 복지 연구소(Australian Institute of Health and Welfare)는 호주 정부 기관으로, 1,210만 건의 병원 입원 사례 중 15만 건이 합병증을 동반했으며, 이 중 의료 관련 감염이 37%를 차지했으며, 이어 정신 혼란(13%), 심장 합병증(12%), 호흡기 문제(10%)가 뒤를 이었습니다. 따라서 병원 내 감염률의 증가가 의료용 항균 코팅에 대한 수요를 촉진하고 있습니다.

의료용 항균 코팅 시장 선도 기업들은 항생제 내성 증가 없이 임플란트 관련 감염 위험을 줄이고 고위험 수술 절차의 치료 결과를 개선하기 위해 비방출성 살균 코팅과 같은 고급 기술 개발을 우선순위로 두고 있습니다. 비방출성 살균 코팅은 항균 물질을 체내로 방출하지 않고 접촉 시 세균을 죽이는 표면 처리 기술입니다. 예를 들어, 2024년 4월 미국 의료 기술 기업 Onkos Surgical은 새로운 항균 코팅이 적용된 정형외과 임플란트에 대해 FDA De Novo 승인을 받았습니다. 이 임플란트는 영구 임플란트 수술에서 중요한 문제인 세균 오염을 방지하도록 특별히 설계되었습니다. 이러한 감염은 면역력이 약한 환자가 많은 정형외과 종양학 및 재수술 관절 치환술에서 특히 위험합니다. 이 코팅 기술은 항생제 사용 없이 감염 위험을 최소화하도록 설계되어 복잡한 정형외과 수술을 받는 고위험 환자 보호에 중요한 진전을 의미합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Medical antibacterial coatings are specialized surface treatments applied to medical devices, implants, instruments, and healthcare surfaces to prevent bacterial growth and lower the risk of infection. These coatings incorporate agents like silver ions, copper, antibiotics, or antimicrobial polymers that either kill bacteria upon contact or inhibit their adhesion. They are commonly used on catheters, surgical tools, wound dressings, and frequently touched hospital surfaces to enhance patient safety and reduce the incidence of hospital-acquired infections (HAIs).

The primary types of medical antibacterial coatings include silver-based, copper-based, polymer-based, and other coating types. Silver-based coatings involve antimicrobial treatments that use silver compounds such as silver nitrate, silver sulfadiazine, or nano-silver to suppress bacterial growth and help prevent infections. These coatings are applied across a range of uses, including implantable devices, surgical instruments, and catheters, serving various end-users such as hospitals, ambulatory surgical centers, diagnostic facilities, and other healthcare settings.

The medical antibacterial coating market research report is one of a series of new reports from The Business Research Company that provides medical antibacterial coating market statistics, including the medical antibacterial coating industry global market size, regional shares, competitors with the medical antibacterial coating market share, detailed medical antibacterial coating market segments, market trends, and opportunities, and any further data you may need to thrive in the medical antibacterial coating industry. This medical antibacterial coating market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The medical antibacterial coating market size has grown rapidly in recent years. It will grow from $5.62 billion in 2024 to $6.21 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. Growth during the historic period can be attributed to the increase in hospital-acquired infections, greater usage of catheters and implants, an expanding geriatric population, a rise in surgical procedures, growing concerns over antibiotic resistance, heightened demand for sterile environments, stronger regulatory emphasis on infection control, increased awareness of hygiene in healthcare settings, expansion of healthcare infrastructure, and the adoption of silver-based coatings.

The medical antibacterial coating market size is expected to see rapid growth in the next few years. It will grow to $9.16 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The projected growth during the forecast period can be linked to the expansion of outpatient surgical centers, the rising burden of chronic diseases, growing demand for minimally invasive medical devices, heightened focus on patient safety, the development of home healthcare services, increased use of disposable medical products, implementation of stricter infection control policies, greater investments in healthcare infrastructure, an aging population in developed regions, and the need for durable coating solutions. Key trends anticipated during this period include the emergence of nanotechnology-based coatings, use of bio-based antimicrobial agents, development of multifunctional coatings, smart-release coating systems, integration of silver nanoparticles, polymeric biocide coatings, advancements in plasma coating technologies, incorporation of antimicrobial peptides, combination antimicrobial strategies, and self-cleaning antimicrobial surfaces.

The increasing prevalence of hospital-acquired infections (HAIs) is expected to drive the growth of the medical antibacterial coating market in the coming years. Hospital-acquired infections are infections that patients contract while receiving treatment in a healthcare facility, which were not present at the time of their admission. The rise in HAIs is largely attributed to factors such as overcrowded hospital environments that promote the transmission of pathogens among at-risk patients. Medical antibacterial coatings help mitigate these infections by preventing the growth and spread of harmful microorganisms on medical equipment and surfaces, thereby improving hygiene standards and ensuring patient safety. For example, in April 2025, the Australian Institute of Health and Welfare, a government agency in Australia, reported that out of 12.1 million hospital admissions, 150,000 cases involved complications, with healthcare-associated infections accounting for 37%, followed by delirium (13%), cardiac complications (12%), and respiratory issues (10%). Thus, the rising rate of hospital-acquired infections is fueling the demand for medical antibacterial coatings.

Leading companies in the medical antibacterial coating market are prioritizing the development of advanced innovations, such as non-eluting bactericidal coatings, to lower the risk of implant-associated infections without contributing to antibiotic resistance, while improving outcomes in high-risk surgical procedures. A non-eluting bactericidal coating is a type of surface treatment that kills bacteria upon contact without releasing antimicrobial substances into the body. For example, in April 2024, Onkos Surgical, a U.S.-based medical technology firm, received FDA De Novo approval for its novel antibacterial-coated orthopedic implants. These implants are specifically designed to prevent bacterial contamination, a critical concern in permanent implant surgeries. Such infections pose a heightened threat in orthopedic oncology and revision arthroplasty, where patients often have weakened immune systems. The coating technology is intended to minimize infection risk without the use of antibiotics, representing a major step forward in protecting high-risk patients undergoing complex orthopedic procedures.

In April 2022, CEMMA Medical, a medical company based in Taiwan, entered into a partnership with LipoCoat to develop a coated central venous catheter (CVC) focused on sustainable infection prevention. The partnership is centered on utilizing LipoCoat's bio-inspired, non-leaching antibacterial coating to prevent bacterial adhesion. LipoCoat is a Netherlands-based company that specializes in producing medical antibacterial coatings aimed at improving the safety, comfort, and performance of medical devices.

Major players in the medical antibacterial coating market are BASF SE, The Sherwin-Williams Company, PPG Industries Inc., Royal DSM N.V., Akzo Nobel N.V., Nippon Paint Holdings Co. Ltd., RPM International Inc., Axalta Coating Systems Ltd., Hempel A/S, Specialty Coating Systems Inc., Sciessent LLC, Bactiguard Holding AB, Sono-Tek Corporation, Harland Medical Systems Inc., Plastic Coatings Limited, Covalon Technologies Ltd., BioCote Limited, AST Products Inc., Mitsubishi Chemical Group Corporation, and Hydromer Inc.

North America was the largest region in the medical antibacterial coating market in 2024. The regions covered in medical antibacterial coating report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the medical antibacterial coating market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical antibacterial coating market consists of sales of titanium dioxide (TiO2) coatings, antifouling coatings, and graphene-based coatings. Values in this market are 'factory gate' values-that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Antibacterial Coating Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical antibacterial coating market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for medical antibacterial coating ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical antibacterial coating market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Medical Antibacterial Coating Market Characteristics

3. Medical Antibacterial Coating Market Trends And Strategies

4. Medical Antibacterial Coating Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Medical Antibacterial Coating Growth Analysis And Strategic Analysis Framework

6. Medical Antibacterial Coating Market Segmentation

7. Medical Antibacterial Coating Market Regional And Country Analysis

8. Asia-Pacific Medical Antibacterial Coating Market

9. China Medical Antibacterial Coating Market

10. India Medical Antibacterial Coating Market

11. Japan Medical Antibacterial Coating Market

12. Australia Medical Antibacterial Coating Market

13. Indonesia Medical Antibacterial Coating Market

14. South Korea Medical Antibacterial Coating Market

15. Western Europe Medical Antibacterial Coating Market

16. UK Medical Antibacterial Coating Market

17. Germany Medical Antibacterial Coating Market

18. France Medical Antibacterial Coating Market

19. Italy Medical Antibacterial Coating Market

20. Spain Medical Antibacterial Coating Market

21. Eastern Europe Medical Antibacterial Coating Market

22. Russia Medical Antibacterial Coating Market

23. North America Medical Antibacterial Coating Market

24. USA Medical Antibacterial Coating Market

25. Canada Medical Antibacterial Coating Market

26. South America Medical Antibacterial Coating Market

27. Brazil Medical Antibacterial Coating Market

28. Middle East Medical Antibacterial Coating Market

29. Africa Medical Antibacterial Coating Market

30. Medical Antibacterial Coating Market Competitive Landscape And Company Profiles

31. Medical Antibacterial Coating Market Other Major And Innovative Companies

32. Global Medical Antibacterial Coating Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Antibacterial Coating Market

34. Recent Developments In The Medical Antibacterial Coating Market

35. Medical Antibacterial Coating Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기